William P. Tew
Directeur Général chez GlycoMira Therapeutics, Inc.
Profil
William P.
Tew is the founder of Cangene bioPharma LLC, which was founded in 1980.
He held the titles of Chairman & Chief Executive Officer from 1980 to 1999.
Currently, he is the Chief Executive Officer of GlycoMira Therapeutics, Inc. Dr. Tew's former positions include President & Chief Executive Officer of Glycosan BioSystems, Inc., Director of Carterra, Inc., Chief Commercial Officer of Lineage Cell Therapeutics, Inc. from 2011 to 2015, Advisory Board Member of NMGF Management LLC, and Vice President-Business Development of OrthoCyte Corp.
Dr. Tew received a doctorate degree from the University of Idaho in 1976.
Postes actifs de William P. Tew
| Sociétés | Poste | Début |
|---|---|---|
GlycoMira Therapeutics, Inc.
 GlycoMira Therapeutics, Inc. BiotechnologyHealth Technology GlycoMira Therapeutics, Inc. is a preclinical-stage biopharmaceutical company based in Salt Lake City, UT. The private company is dedicated to improving the standard of care and outcomes for patients with cancer and other inflammatory diseases. GlycoMira is developing a new class of innate immune system modulators based on polysaccharides that naturally occur within the body. The company's lead drug candidate, GM-1111, has demonstrated potential to address unmet needs in solid tumor treatment and supportive care. The CEO of the company is William P. Tew. | Directeur Général | - |
Anciens postes connus de William P. Tew
| Sociétés | Poste | Fin |
|---|---|---|
| LINEAGE CELL THERAPEUTICS, INC. | Corporate Officer/Principal | 01/01/2015 |
Cangene bioPharma LLC
 Cangene bioPharma LLC BiotechnologyHealth Technology Cangene bioPharma LLC provides commercial drug production services. It offers ecosystem studies and restoration science, fisheries, and environmental chemistry and toxicology services. The company was founded by William P. Tew, Paul Wilks and Samuel Cross in 1980 and is headquartered in Solomons, MD. | Fondateur | 01/01/1999 |
OrthoCyte Corp.
 OrthoCyte Corp. Pharmaceuticals: MajorHealth Technology Part of Lineage Cell Therapeutics, Inc., OrthoCyte Corp. develops cellular therapeutics for orthopedic repair diseases and injuries. The company is based in Alameda, CA. The CEO of the company is Michael D. West. | Corporate Officer/Principal | - |
Glycosan BioSystems, Inc.
 Glycosan BioSystems, Inc. Pharmaceuticals: MajorHealth Technology Glycosan BioSystems, Inc. develops, manufactures, and markets formulations of a hyaluronan-based synthetic extra cellular matrix. Its products are used cell culture, stem cell culture, tissue engineering, and cell therapy. The company was founded by Glenn Prestwich, William Tew, and Anna Scott in January 2006 and is located in Salt Lake City, UT. | President | - |
Carterra, Inc.
 Carterra, Inc. Medical SpecialtiesHealth Technology Carterra, Inc. engages in provision of innovative technologies designed to accelerate the discovery of novel therapeutic candidates. It offers Kinetics software, Epitope mapping, therapeutic areas, and antibody formats. The company was founded by James Smith and Josh Eckman in 2005 and is headquartered in Salt Lake City, UT. | Directeur/Membre du Conseil | - |
Formation de William P. Tew
| University of Idaho | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| LINEAGE CELL THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 6 |
|---|---|
Cangene bioPharma LLC
Cangene bioPharma LLC BiotechnologyHealth Technology Cangene bioPharma LLC provides commercial drug production services. It offers ecosystem studies and restoration science, fisheries, and environmental chemistry and toxicology services. The company was founded by William P. Tew, Paul Wilks and Samuel Cross in 1980 and is headquartered in Solomons, MD. | Health Technology |
Carterra, Inc.
Carterra, Inc. Medical SpecialtiesHealth Technology Carterra, Inc. engages in provision of innovative technologies designed to accelerate the discovery of novel therapeutic candidates. It offers Kinetics software, Epitope mapping, therapeutic areas, and antibody formats. The company was founded by James Smith and Josh Eckman in 2005 and is headquartered in Salt Lake City, UT. | Health Technology |
Glycosan BioSystems, Inc.
Glycosan BioSystems, Inc. Pharmaceuticals: MajorHealth Technology Glycosan BioSystems, Inc. develops, manufactures, and markets formulations of a hyaluronan-based synthetic extra cellular matrix. Its products are used cell culture, stem cell culture, tissue engineering, and cell therapy. The company was founded by Glenn Prestwich, William Tew, and Anna Scott in January 2006 and is located in Salt Lake City, UT. | Health Technology |
NMGF Management LLC
 NMGF Management LLC Investment ManagersFinance NMGF Management LLC (New Markets Venture Partners) is a venture capital firm founded in 2002 by Mark Anthony Grovic and Robb Tyler Doub. The firm is headquartered in Fulton, Maryland. | Finance |
OrthoCyte Corp.
OrthoCyte Corp. Pharmaceuticals: MajorHealth Technology Part of Lineage Cell Therapeutics, Inc., OrthoCyte Corp. develops cellular therapeutics for orthopedic repair diseases and injuries. The company is based in Alameda, CA. The CEO of the company is Michael D. West. | Health Technology |
GlycoMira Therapeutics, Inc.
GlycoMira Therapeutics, Inc. BiotechnologyHealth Technology GlycoMira Therapeutics, Inc. is a preclinical-stage biopharmaceutical company based in Salt Lake City, UT. The private company is dedicated to improving the standard of care and outcomes for patients with cancer and other inflammatory diseases. GlycoMira is developing a new class of innate immune system modulators based on polysaccharides that naturally occur within the body. The company's lead drug candidate, GM-1111, has demonstrated potential to address unmet needs in solid tumor treatment and supportive care. The CEO of the company is William P. Tew. | Health Technology |